125 related articles for article (PubMed ID: 29813011)
1. Assessment of Provider Adherence to Recommended Monitoring Parameters for Oral Anticancer Medications.
Redelico TJ; Walton SM; LaFollette J; Adams Curry M; Bernal-Mizrachi L
J Oncol Pract; 2018 Jul; 14(7):e446-e450. PubMed ID: 29813011
[TBL] [Abstract][Full Text] [Related]
2. The Association Between Patient-Reported and Objective Oral Anticancer Medication Adherence Measures: A Systematic Review
.
Atkinson TM; Rodríguez VM; Gordon M; Avildsen IK; Emanu JC; Jewell ST; Anselmi KA; Ginex PK
Oncol Nurs Forum; 2016 Sep; 43(5):576-82. PubMed ID: 27541550
[TBL] [Abstract][Full Text] [Related]
3. Adherence to Oral Anticancer Medications After Implementation of an Ambulatory Adherence Program at a Large Urban Academic Hospital.
Curry MA; Chineke I; Redelico T; Terrell C; Bell W; Flood D; Mishra P; LaFollette J; Power S; Bernal-Mizrachi L
JCO Oncol Pract; 2020 Apr; 16(4):e350-e356. PubMed ID: 32048938
[TBL] [Abstract][Full Text] [Related]
4. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer oral anti-cancer medication adherence: a systematic review of psychosocial motivators and barriers.
Lin C; Clark R; Tu P; Bosworth HB; Zullig LL
Breast Cancer Res Treat; 2017 Sep; 165(2):247-260. PubMed ID: 28573448
[TBL] [Abstract][Full Text] [Related]
6. Why individual-level interventions are not enough: Systems-level determinants of oral anticancer medication adherence.
Dean LT; George M; Lee KT; Ashing K
Cancer; 2020 Aug; 126(16):3606-3612. PubMed ID: 32438466
[TBL] [Abstract][Full Text] [Related]
7. Assessing the need for improved strategies and medication-related education to increase adherence for oral anticancer medications in the young adult oncology population.
Divakaruni A; Saylor E; Duffy AP
J Oncol Pharm Pract; 2018 Jul; 24(5):337-342. PubMed ID: 28387636
[TBL] [Abstract][Full Text] [Related]
8. Adherence to targeted oral anticancer medications.
Geynisman DM; Wickersham KE
Discov Med; 2013 Apr; 15(83):231-41. PubMed ID: 23636140
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analyses of targeted oral anti-cancer drugs: a systematic review.
Smieliauskas F; Chien CR; Shen C; Geynisman DM; Shih YC
Pharmacoeconomics; 2014 Jul; 32(7):651-80. PubMed ID: 24821281
[TBL] [Abstract][Full Text] [Related]
10. The effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients in ambulatory care settings: a systematic review.
Arthurs G; Simpson J; Brown A; Kyaw O; Shyrier S; Concert CM
JBI Database System Rev Implement Rep; 2015 Jun; 13(5):244-92. PubMed ID: 26455611
[TBL] [Abstract][Full Text] [Related]
11. Oral Anticancer Medication Adherence, Toxicity Reporting, and Counseling: A Study Comparing Health Care Providers and Patients.
Gandhi S; Day L; Paramsothy T; Giotis A; Ford M; Boudreau A; Pasetka M
J Oncol Pract; 2015 Nov; 11(6):498-504. PubMed ID: 26395564
[TBL] [Abstract][Full Text] [Related]
12. Adherence to recommended dosing and monitoring for mitoxantrone in patients with multiple sclerosis: a healthcare claims database study supplemented with medical records--the RETRO study.
Funch D; Norman H; Wong J; Bennett R; Hillier J; Al-Sabbagh A; Seeger JD
Pharmacoepidemiol Drug Saf; 2010 May; 19(5):448-56. PubMed ID: 20333778
[TBL] [Abstract][Full Text] [Related]
13. The impact of a pharmacist-led oral anticancer clinic on medication adherence and laboratory monitoring.
Megeed A; Magas H; Accursi M; Burant CJ; Hansen E
J Oncol Pharm Pract; 2023 Dec; 29(8):1921-1927. PubMed ID: 37350157
[TBL] [Abstract][Full Text] [Related]
14. Anti-IgE therapy for asthma: an audit at atertiary care centre in Saudi Arabia.
Weheba IM; Abdelsayed AM; Arnaout RK; Zeitouni MO; Mobaireek KF; AlHarthi TB; Mobeireek AF
Ann Saudi Med; 2018; 38(6):439-444. PubMed ID: 30531179
[TBL] [Abstract][Full Text] [Related]
15. Barriers to physician adherence to evidence-based monitoring guidelines in chronic myelogenous leukemia.
Goldberg SL; Akard LP; Dugan MJ; Faderl S; Pecora AL
J Oncol Pract; 2015 May; 11(3):e398-404. PubMed ID: 25758446
[TBL] [Abstract][Full Text] [Related]
16. Assessment and utilization of rapid virologic response in US veterans with chronic hepatitis C: evaluating provider adherence to practice guidelines.
Hwang EW; Thomas IC; Cheung R; Backus LI
J Clin Gastroenterol; 2013 Mar; 47(3):264-70. PubMed ID: 23269309
[TBL] [Abstract][Full Text] [Related]
17. Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines.
Manteuffel M; Williams S; Chen W; Verbrugge RR; Pittman DG; Steinkellner A
J Womens Health (Larchmt); 2014 Feb; 23(2):112-9. PubMed ID: 24206025
[TBL] [Abstract][Full Text] [Related]
18. Improving Practice Guideline Adherence Through Peer Feedback: Impact of an Ambulatory Cardiology Curriculum.
Richardson KM; Singh J; Muñoz D; Damp JB; Mendes LA
Teach Learn Med; 2018; 30(3):328-336. PubMed ID: 29364732
[TBL] [Abstract][Full Text] [Related]
19. Initial experience with antiarrhythmic medication monitoring by clinical pharmacists in an outpatient setting: a retrospective review.
Snider M; Kalbfleisch S; Carnes CA
Clin Ther; 2009 Jun; 31(6):1209-18. PubMed ID: 19695388
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the prescribing patterns, adverse effects, and drug interactions of oral chemotherapy agents in an outpatient cancer center.
Solomon JM; Ajewole VB; Schneider AM; Sharma M; Bernicker EH
J Oncol Pharm Pract; 2019 Oct; 25(7):1564-1569. PubMed ID: 30170514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
